NEW YORK, March 16 (GenomeWeb News) - Accelr8 Technology today reported growing losses and shrinking revenues for the second quarter of its fiscal year 2004.

 

The company booked $153,000 in revenues for the quarter, which ended Jan. 31, down from $202,000 during the same period a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.